Spotlight on Bristol-Myers Squibb: Analyzing the Surge in Options Activity
Spotlight on Bristol-Myers Squibb: Analyzing the Surge in Options Activity
Deep-pocketed investors have adopted a bearish approach towards Bristol-Myers Squibb (NYSE:BMY), and it's something market players shouldn't ignore. Our tracking of public options records at Benzinga unveiled this significant move today. The identity of these investors remains unknown, but such a substantial move in BMY usually suggests something big is about to happen.
有錢的投資者對施貴寶（Bristol-Myers Squibb，紐交所：BMY）持看淡態度，市場參與者不應忽視。我們在Benzinga追蹤的公共期權記錄中發現了這一重要動向。這些投資者的身份仍然未知，但在BMY中發生如此重大的變動通常意味着即將發生重大事件。
We gleaned this information from our observations today when Benzinga's options scanner highlighted 8 extraordinary options activities for Bristol-Myers Squibb. This level of activity is out of the ordinary.
我們從觀察中獲得了這些信息，當Benzinga的期權掃描器突出顯示施貴寶的8項非凡期權活動時。這種活動水平是超出平常限度的。
The general mood among these heavyweight investors is divided, with 25% leaning bullish and 50% bearish. Among these notable options, 5 are puts, totaling $243,460, and 3 are calls, amounting to $196,260.
這些重量級投資者的情緒是分歧的，25%傾向看好，50%看淡。在這些重要期權中，5爲看跌，總額爲243,460美元，3爲看漲，總額爲196,260美元。
What's The Price Target?
價格目標是什麼？
Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range from $40.0 to $47.0 for Bristol-Myers Squibb over the last 3 months.
考慮到這些合同的成交量和持倉量，似乎過去3個月鯨魚一直在以40.0到47.0美元的價格區間中針對施貴寶進行報價。
Insights into Volume & Open Interest
成交量和持倉量分析
Looking at the volume and open interest is a powerful move while trading options. This data can help you track the liquidity and interest for Bristol-Myers Squibb's options for a given strike price. Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of Bristol-Myers Squibb's whale trades within a strike price range from $40.0 to $47.0 in the last 30 days.
觀察成交量和持倉量是交易期權的強有力手段。這些數據可以幫助您跟蹤施貴寶在給定執行價的期權的流動性和興趣。下面，我們可以觀察施貴寶所有鯨魚交易的看漲期權和看跌期權的成交量和持倉量的變化，這些交易在過去30天內在40.0到47.0美元的執行價區間內完成。
Bristol-Myers Squibb 30-Day Option Volume & Interest Snapshot
施貴寶30天期權成交量和未平倉合約快照
Largest Options Trades Observed:
觀察到的最大期權交易：
| Symbol | PUT/CALL | Trade Type | Sentiment | Exp. Date | Ask | Bid | Price | Strike Price | Total Trade Price | Open Interest | Volume |
|---|---|---|---|---|---|---|---|---|---|---|---|
| BMY | CALL | TRADE | BEARISH | 03/21/25 | $3.6 | $3.45 | $3.5 | $42.00 | $96.2K | 616 | 0 |
| BMY | CALL | SWEEP | BULLISH | 01/16/26 | $6.4 | $6.35 | $6.4 | $40.00 | $56.9K | 4.3K | 1 |
| BMY | PUT | SWEEP | BEARISH | 12/18/26 | $10.95 | $9.35 | $9.4 | $47.00 | $56.4K | 1 | 151 |
| BMY | PUT | TRADE | NEUTRAL | 12/18/26 | $9.85 | $8.8 | $9.4 | $47.00 | $47.0K | 1 | 101 |
| BMY | PUT | TRADE | BEARISH | 12/18/26 | $9.85 | $8.6 | $9.4 | $47.00 | $47.0K | 1 | 1 |
| 標的 | 看跌/看漲 | 交易類型 | 情緒 | 到期日 | 賣盤 | 買盤 | 價格 | 執行價格 | 總交易價格 | 未平倉合約數量 | 成交量 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| BMY | 看漲 | 交易 | 看淡 | 03/21/25 | $3.6 | $3.45 | $3.5 | 根據TipRanks.com數據，Gruber是一位5星分析師，平均回報率爲14.5％，成功率爲60.5％。Gruber主要研究北美板塊的股票，重點關注Solaris Oilfield Infrastructure、Oceaneering International和Atlas Energy Solutions等股票。 | $96.2K | 616 | 0 |
| BMY | 看漲 | SWEEP | 看好 | 01/16/26 | 6.4美元 | $ 6.35 | 6.4美元 | $40.00 | $56.9K | 4.3千 | 1 |
| BMY | 看跌 | SWEEP | 看淡 | 12/18/26 | $10.95 | $9.35 | 9.4美元 | $47.00 | $56.4K | 1 | 151 |
| BMY | 看跌 | 交易 | 中立 | 12/18/26 | $9.85 | $ 8.8 | 9.4美元 | $47.00 | $47.0千美元 | 1 | 101 |
| BMY | 看跌 | 交易 | 看淡 | 12/18/26 | $9.85 | $8.6美元 | 9.4美元 | $47.00 | $47.0千美元 | 1 | 1 |
About Bristol-Myers Squibb
關於施貴寶
Bristol-Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Bristol derives close to 70% of total sales from the U.S., showing a higher dependence on the U.S. market than most of its peer group.
施貴寶發現、開發和營銷用於心血管疾病、癌症和免疫障礙等多種治療領域的藥品。施貴寶的重點關注點是免疫腫瘤學，該公司是藥品研發領域的領導者。施貴寶近70%的總銷售額來自美國，顯示了該公司對美國市場的更高依賴性，高於其大多數同行。
In light of the recent options history for Bristol-Myers Squibb, it's now appropriate to focus on the company itself. We aim to explore its current performance.
鑑於施貴寶最近的期權歷史，現在適合關注公司本身。我們的目標是探索其當前表現。
Where Is Bristol-Myers Squibb Standing Right Now?
施貴寶目前處於什麼位置？
- Currently trading with a volume of 2,180,706, the BMY's price is up by 0.32%, now at $40.99.
- RSI readings suggest the stock is currently is currently neutral between overbought and oversold.
- Anticipated earnings release is in 16 days.
- 目前成交量爲2,180,706，BMY的價格上漲了0.32％，現在爲40.99美元。
- RSI讀數表明該股票目前處於中立狀態，處於超買和超賣之間。
- 預計16天后發佈收益報告。
Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.
期權與僅交易股票相比是一種更具風險的資產，但它們具有更高的利潤潛力。認真的期權交易者通過每日學習，進出交易，跟隨多個指標並密切關注市場來管理這種風險。